Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix

Journal: Journal of Clinical Investigation

Published: 2020-09-01

DOI: 10.1172/jci136760

Affiliations: 20

Authors: 23

Go to article
Institutions Share
UCSF Department of Medicine (DOM), United States of America (USA) 0.11
UCSF Helen Diller Family Comprehensive Cancer Center, United States of America (USA) 0.11
UCSF Center for Bioengineering and Tissue Regeneration, United States of America (USA) 0.09
Bristol-Myers Squibb (BMS), United States of America (USA) 0.09
UCSF Department of Pathology, United States of America (USA) 0.09
Perthera, Inc., United States of America (USA) 0.06
UNC Rex Healthcare, United States of America (USA) 0.04
Eppley Institute for Research in Cancer and Allied Diseases, UNMC, United States of America (USA) 0.04
UCSF Department of Radiology and Biomedical Imaging, United States of America (USA) 0.04
Foundation Medicine, Inc., United States of America (USA) 0.04
Charité Institute of Pathology, Germany 0.04
Heidelberg University Hospital at Medical Faculty Heidelberg, Uni Heidelberg, Germany 0.04
DKTK Partner Site Munich, Germany 0.04
TUM Institute of Pathology, Germany 0.04
Department of Surgery, CU Anschutz, United States of America (USA) 0.04
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, United States of America (USA) 0.03
UNC Lineberger Comprehensive Cancer Center, United States of America (USA) 0.01
UNC Department of Surgery, United States of America (USA) 0.01
UNC Department of Pharmacology, United States of America (USA) 0.01

Return